A Phase III, Randomized, Double-Blind, Controlled Study (PEMPHIX) to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Patients With Pemphigus Vulgaris. J of Skin. 2020;4(1):S26. Accessed April 19, 2026. https://skin.dermsquared.com/skin/article/view/806